ライフサイエンスコーパス: activator protein

1 tion the smaller regulons (bacteriorhodopsin-activator protein).

2 sion by Cdk5 requires its binding to the p35 activator protein.

3 engagement with its cognate ATP-hydrolyzing activator protein.

4 ase requires the action of a transcriptional activator protein.

5 may occur through increased levels of AR co-activator proteins.

6 ted by phosphorylation and by the binding of activator proteins.

7 RNA, the translation machinery and decapping activator proteins.

8 A polymerase II and upstream transcriptional activator proteins.

9 ted T-cells (NFAT) c1, whereas NF-kappaB and activator protein 1 (AP-1) activation were not adversely

10 nase, and phospho-cJun, as well as decreased activator protein 1 (AP-1) activity.

11 cription factors nuclear factor (NF)-kappaB, activator protein 1 (AP-1) and CCAAT/enhancer binding pr

12 ed HSPC specification by activating a unique activator protein 1 (AP-1) and runx1 transcription progr

13 nhancer of activated B cells (NF-kappaB) and activator protein 1 (AP-1) are transcription factors act

14 Radiation-induced AC gene transactivation by activator protein 1 (AP-1) binding on the proximal promo

15 c-Jun transcription factors, members of the activator protein 1 (AP-1) complex, form heterodimers an

16 2-related factor 2 (Nrf2) and members of the activator protein 1 (AP-1) family of proteins.

17 f interferon regulatory factor 4 (IRF4) with activator protein 1 (AP-1) family proteins and STAT3 in

18 ctor 7) are highly homologous members of the activator protein 1 (AP-1) family.

19 Activator protein 1 (AP-1) is a pivotal transcription fa

20 T: Activator protein 1 (AP-1) is a transcription factor tha

21 d to measure the effect of Smad3, MAPKs, and activator protein 1 (AP-1) on TGFbeta-mediated CCN3 prom

22 measure the effects of Smads 2, 3, and 7 and activator protein 1 (AP-1) on TGFbeta-mediated CTGF prom

23 factors nuclear factor kappaB (NFkappaB) and activator protein 1 (AP-1) regulate key proinflammatory

24 a cyclic AMP response element (CRE) and two activator protein 1 (AP-1) response elements in the muri

25 FAT), nuclear factor kappaB (NF-kappaB), and activator protein 1 (AP-1) to induce type 2 cytokines.

26 Hypoxia-inducible factor 1 (HIF-1) and activator protein 1 (AP-1) transcription complexes were

27 The actin-binding protein Ezrin and the activator protein 1 (AP-1) transcription factor are impl

28 Activation of the activator protein 1 (AP-1) transcription factor as well

29 ding enhancer element that contains multiple activator protein 1 (AP-1) transcription factor binding

30 d, and normal cellular FOS forms part of the activator protein 1 (AP-1) transcription factor complex,

31 JUN proto-oncogene, which forms part of the activator protein 1 (AP-1) transcription factor complex.

32 The Activator Protein 1 (AP-1) transcription factor subunit

33 K activation was required for the binding of activator protein 1 (AP-1) transcription factor to the M

34 Activator protein 1 (AP-1) transcription factors become

35 Following shear-flow exposure, six activator protein 1 (AP-1) transcripts (ATF4,JUNB,JUN,FO

36 The expression of the activator protein 1 (AP-1) was increased in lung tissues

37 Additionally, activator protein 1 (AP-1) was shown to be essential in

38 mponent of the transcription factor complex, activator protein 1 (AP-1), and promoted SIRT1 associati

39 We found that activator protein 1 (AP-1), Ets related gene (Erg) and G

40 ellular signal-regulated kinase 1/2 (Erk1/2)-activator protein 1 (AP-1), known collectively as the Ra

41 downstream target gene c-fos, a component of activator protein 1 (AP-1), that directly regulates epit

42 inal kinase (JNK), results in stimulation of activator protein 1 (AP-1), which promotes gene transcri

43 promoter and exhibit a strong enrichment for activator protein 1 (AP-1)-binding events, suggesting th

44 Activator protein 1 (AP-1, also known as JUN) transcript

45 bital-responsive enhancer module (PREM), and activator protein 1 (AP-1-) -driven pathways.

46 ensus DNA sequence for transcription factors activator protein 1 (AP1) and specificity protein 1 (SP1

47 high-throughput sequencing, we identify the activator protein 1 (AP1) as a major partner for product

48 Deregulation of the activator protein 1 (AP1) family gene regulators has bee

49 The activator protein 1 (AP1) family transcription factor BA

50 extracellular signal-regulated kinase (Erk)-activator protein 1 (Ap1) pathway seems to mediate the e

51 ein (CHOP), X2-Box-binding protein 1 (XBP1), activator protein 1 (AP1), SMAD, CCAAT/enhancer-binding

52 we identified several functional NF-kappaB, activator protein 1 (AP1), STAT, and Smad DBS in the TSL

53 on in nonsteroidogenic cells, likely through activator protein 1 (AP1).

54 affect the ubiquitin-editing enzyme A20 and activator protein 1 (AP1).

55 sion that is mediated by DNA-bound NF-kappaB/activator protein 1 (AP1)/STAT3 activators and instrumen

56 Repressor activator protein 1 (RAP1) and telomeric repeat-binding

57 Repressor/activator protein 1 (RAP1) is a highly conserved telomer

58 Repressor activator protein 1 (Rap1) performs multiple vital cellu

59 ide direct evidence that the yeast repressor/activator protein 1 (Rap1), tightly bound to its consens

60 ct contact with the transactivator repressor activator protein 1 (Rap1).

61 TbPIP5Pase associates with repressor/activator protein 1 (TbRAP1), and their telomeric silenc

62 ytokine secretion, nuclear factor kappaB and activator protein 1 activation, mitogen-activated protei

63 by multiple transcription factors, including activator protein 1 and cAMP response element-binding pr

64 and miR-466l regulated transcription factors activator protein 1 and nuclear factor kappaB1 in miRNA

65 rosis factor alpha expression, and increased activator protein 1 and nuclear factor-kappaB transcript

66 s: extracellular signal-regulated kinase 1/2-activator protein 1 and signal transducer and activator

67 d a trend for increased NF-AT, but decreased activator protein 1 and similar NF-kappaB, activity in C

68 late Mmp13 expression via the P2rx7/MAPK/ERK/activator protein 1 axis.

69 ing of a phosphorylated c-Jun containing the activator protein 1 complex to the PUMA promoter was ide

70 X1, PREP1 induces the expression of multiple activator protein 1 components including the proinvasive

71 These results demonstrate that the c-Jun/activator protein 1 pathway is critical for maintaining

72 tivated the mitogen-activated protein kinase/activator protein 1 pathway, together with the inflammas

73 its target gene programmed cell death 4 and activator protein 1 pathway.

74 llular injury response through PDCD4 and the activator protein 1 pathway.

75 ceptor gamma agonist rosiglitazone decreased activator protein 1 promoter activity.

76 Our findings demonstrate that the JNK/activator protein 1 signaling pathway underlies the mela

77 ated by cyclooxygenase/nuclear factor-kappaB/activator protein 1 signaling pathways.

78 l-regulated kinase 1/2 pathway, involving an activator protein 1 site in MMP10 gene promoter.

79 binding of c-Fos and c-Jun to Mmp-9 promoter activator protein 1 sites.

80 Batf belongs to the activator protein 1 superfamily of basic leucine zipper

81 a highly conserved member of the multimeric activator protein 1 transcription factor complex and pla

82 suprabasal epidermis-specific inhibition of activator protein 1 transcription factor signaling.

83 kappaB p65, and the nuclear translocation of activator protein 1 transcription factor.

84 ough serine 84 phosphorylation and promoting activator protein 1 transcription.

85 tion and nuclear factor of activated T cells/activator protein 1 transcriptional activity.

86 Although the c-Jun/activator protein 1 transcriptional factor regulates cel

87 Moreover, activator protein 1 was a downstream signaling molecule

88 AP-1 (activator protein 1) activity is strongly induced in res

89 ly conserved JNK/AP-1 (Jun N-terminal kinase/activator protein 1) and BMP (Bone Morphogenetic Protein

90 3beta (hepatocyte nuclear factor 3) and AP-1(activator protein 1) as proteins likely to be involved i

91 Rap1 (repressor activator protein 1) is a conserved multifunctional prot

92 the telomere-binding protein Rap1 (repressor activator protein 1) relocalizes to the upstream promote

93 g CD4(+) T cell activation: NF-kappaB, AP-1 (activator protein 1), and NFAT (nuclear factor of activa

94 ctivator, but not activator Rap1p (repressor-activator protein 1).

95 h the JNK pathway, reduced the activation of activator protein 1, and decreased the expression of MMP

96 g of transcription factors nuclear factor-Y, activator protein 1, and specificity protein 1, respecti

97 on of the inflammatory transcription factor, activator protein 1, but not NF-kappaB was observed.

98 ssive activation of the transcription factor activator protein 1, reduced histone deacetylase-2 (HDAC

99 Soluble LT also led to the activation of activator protein 1, whereas LT(+) vesicle IL-6 response

100 by COOH-truncated HBx was abolished when the activator protein 1-binding sites on the MMP10 promoter

101 r; competition with the transcription factor activator protein 1; and reduced expression of histone d

102 ization of their regulators (Rap1 [repressor activator protein 1], Fhl1, Ifh1, Sfp1, and Hmo1), the t

103 ated with an increase in VEGF transcription, activator protein-1 (AP-1) activity, and JunB accumulati

104 Fos and Jun are components of activator protein-1 (AP-1) and play crucial roles in the

105 Previously, we implicated Akt and activator protein-1 (AP-1) as mediators of growth and ge

106 ent on nuclear factor-kappaB (NF-kappaB) and activator protein-1 (AP-1) binding and sensitive to phar

107 n addition, we found that MTA1/polymerase II/activator protein-1 (AP-1) co-activator complex interact

108 c-Jun is a component of the activator protein-1 (AP-1) complex, which plays a crucia

109 -/-)/Apc(Min/+) showed dramatic increases in activator protein-1 (AP-1) DNA binding, and SOCS2 overex

110 Here we show the activator protein-1 (AP-1) factor JunB is an essential r

111 The activator protein-1 (AP-1) family transcription factor,

112 n about the role of the transcription factor activator protein-1 (AP-1) in ABC DLBCL.

113 sensus binding site for transcription factor activator protein-1 (AP-1) is required for promoter acti

114 Our studies continue with the Jun/Fos activator protein-1 (AP-1) leucine zipper complex, as it

115 that inhibition of the transcription factor activator protein-1 (AP-1) may contribute to the chemopr

116 in a dose-dependent manner by activating the activator protein-1 (AP-1) member proteins c-FOS, JunD,

117 The levels of activator protein-1 (AP-1) mRNA and protein, as well as

118 Additionally, JunD but not JunB formed an activator protein-1 (AP-1) oligomeric complex to augment

119 Activator protein-1 (AP-1) regulates a wide range of cel

120 Activator protein-1 (AP-1) regulates diverse gene respon

121 0 and IL-12Rbeta2 via inhibition of the MAPK-activator protein-1 (AP-1) signaling pathway.

122 ven genes by attenuating the availability of activator protein-1 (AP-1) sites to Jun family signal-de

123 omoting redistribution of TAp73 from TP53 to activator protein-1 (AP-1) sites.

124 to the pro-inflammatory transcription factor activator protein-1 (AP-1) through protein-protein inter

125 The proto-oncogene c-Jun is a component of activator protein-1 (AP-1) transcription factor complexe

126 nic, linkage and microarray studies that the activator protein-1 (AP-1) transcription factor JunD is

127 is an IDP that acts as a potentiator of the Activator Protein-1 (AP-1) transcription factor.

128 ated TF expression depended most strongly on activator protein-1 (AP-1) transcriptional activity and

129 ranscriptional activation of c-Fos-dependent activator protein-1 (AP-1) via serum response factor (SR

130 e sulfate activates the transcription factor activator protein-1 (AP-1) via stimulation of transient

131 haracteristically contained motifs that bind activator protein-1 (AP-1), a pivotal regulator of infla

132 , such as nuclear factor kappaB (NF-kappaB), activator protein-1 (AP-1), and signal transduction and

133 The transcription factor, activator protein-1 (AP-1), binds to cognate DNA under r

134 cer of activated B cells (NF-kappaB), STAT3, activator protein-1 (AP-1), hypoxia-inducible factor-1 (

135 e-induced promoter activity of NF-kappaB and activator protein-1 (AP-1), indicating that NF-kappaB an

136 which is a component of transcription factor activator protein-1 (AP-1), to the promoter region of mi

137 e transcription factors NF-kappaB itself and activator protein-1 (AP-1).

138 oblast differentiation via the activation of activator protein-1 (AP-1).

139 tion factors such as nuclear factor B (NFB), activator protein-1 (AP1) and heat shock factor 1 (HSF1)

140 ressed, IRF4 unexpectedly can cooperate with activator protein-1 (AP1) complexes to bind to AP1-IRF4

141 ERK activity promoted the expression of the activator protein-1 (AP1) components Fra-1 and c-Jun, bo

142 kappaB) and epidermal growth factor receptor-activator protein-1 (EGFR-AP1) pathways are often co-act

143 ediated mitogen-activated protein kinase and activator protein-1 activation, and epithelial to mesenc

144 phosphorylation is critical for controlling activator protein-1 activity, which is a major driver in

145 dose, many of which are under the control of activator protein-1 and ERK signaling.

146 otein-1 (GRIP1), GR tethers to the DNA-bound activator protein-1 and NF-kappaB and represses transcri

147 9 in vitro, which required activation of the activator protein-1 and nuclear factor-kappaB signaling

148 ivation was specific, inasmuch as binding of activator protein-1 and octameric transcription factor 1

149 tant synapses, c-Jun N-terminal kinase (JNK)/activator protein-1 and TGF-beta signaling were overacti

150 ogic events through the transcription factor activator protein-1 and transcription-independent contro

151 atin immunoprecipitation (ChIP), we detected activator protein-1 binding within an evolutionarily con

152 otein-1 reporter activity, but activation of activator protein-1 by the three SLK mutants was ineffec

153 ivated involucrin promoter activity, nuclear activator protein-1 factor accumulation and binding to D

154 ncreases the expression of ET(A) R, OBRb and activator protein-1 in HSCs.

155 ion of mitogen-activated protein kinases and activator protein-1 in myofibers of mdx mice.

156 AR-small interfering RNA or treated with the activator protein-1 inhibitor SR-11302 [3-methyl-7-(4-me

157 xtracellular signal-regulated kinase 1/2 and activator protein-1 nuclear factors in IL-13Ralpha2-posi

158 kinase 1/2 mitogen-activated protein kinase/activator protein-1 pathway activation.

159 Similarly, SLK WT stimulated activator protein-1 reporter activity, but activation of

160 ERbeta-dependent retardation of migration of activator protein-1 response elements in EMSA.

161 xpression is up-regulated by ROS through the activator protein-1 signaling pathway and promotes cell

162 Hoxc6 activated the oncogenic activator protein-1 signaling pathway through a physical

163 d transcriptional activation of the relevant activator protein-1 site in the human TGFbeta1 promoter.

164 enhanced c-Fos/c-Jun binding to the proximal activator protein-1 site of the StAR promoter in HPAECs,

165 Ser(63) and Ser(73), resulting in increased activator protein-1 transactivation.

166 y our study indicated that MAPK pathways and activator protein-1 transcription factor were involved i

167 IL-1beta signaling converges upon the activator protein-1 transcription factors, which have be

168 by Cav1 knockdown to increased expression of activator protein-1 transcriptional targets, including c

169 receptor 1) was identified as a novel c-Fos/activator protein-1(AP-1)-regulated gene.

170 V6 expression is through EGR1-mediated AP-1 (activator protein-1) activity and that the EGR1- and AP-

171 rotein partner of DeltaFosB binding to AP-1 (activator protein-1) sites of genes, remained unchanged

172 CCL2-regulating transcription factor, AP-1 (activator protein-1).

173 s binding to transcription factors NFkappaB, Activator Protein-1, and CCAAT/enhancer-binding protein

174 55,212-2 acts via PPARalpha to activate JNK, activator protein-1, and positive regulatory domain IV t

175 possibly because of decreased activation of activator protein-1, compared with control cells overexp

176 ing from GPCRs and RhoA to the regulation of activator protein-1, NFkappaB (nuclear factor kappa-ligh

177 tor, endothelin-1 type A receptor (ET(A) R), activator protein-1, transforming growth factor beta (TG

178 ions involving several signaling modulators, activator protein-1-dependent gene expression remains hi

179 the nuclear factor of activated T cell- and activator protein-1-dependent signaling pathways, which

180 y phosphorylation of c-Jun and activation of activator protein-1-dependent transcription.

181 RK2), in turn leading to inhibition of c-Jun/activator protein-1-dependent transcriptional activity.

182 The Transcription Factor Activator Protein 2 (Tfap2) was duplicated in the chorda

183 zfh-2 is controlled by the Drosophila activator protein 2 gene and regulates the late expressi

184 (betaAR), cAMP and the transcription factor activator protein-2 (AP-2) are contributors to the Abeta

185 (VSMCs), resulting in the phosphorylation of activator protein 2alpha (AP-2alpha) and consequent matr

186 These studies examined the role of activator protein 2alpha (AP2), an inducer of TGF-alpha

187 ectly responsive to the transcription factor activator protein 2C (TFAP2C).

188 Like native transcriptional activator proteins, an ATA must minimally contain a DNA-

189 nisms underlying the function of KLF14 as an activator protein and novel regulator of lipid signaling

190 g an auto-regulatory loop involving the YdeO activator protein and novel roles for the PhoP protein.

191 nucleosome-remodeling complexes recruited by activator proteins and elongating RNA polymerase II.

192 transcription factors, TFIIS, the Pho4 gene activator protein, and the SAGA, SWI/SNF, and Mediator c

193 t, including the short-lived activity of the activator protein, and the time-of-day when induction an

194 genes transcribed by promoters containing an activator protein (AP)-1 binding site were significantly

195 ylation of c-Fos and formation of a specific activator protein (AP)-1 complex.

196 endothelial NF-kappaB pathway activated the activator protein (AP)-1 pathway (NF-kappaB-to-AP-1 swit

197 lar growth and potentiate transactivation of activator protein (AP)-1 target genes such as cyclin D1.

198 in-enhancer of activated B cells (NF-kB) and activator protein (AP)-1 through regulation of their tar

199 fferentiation, we cloned SARI (suppressor of activator protein (AP)-1, regulated by interferon (IFN))

200 Overexpression of the activator protein (AP)-2gamma transcription factor in br

201 EVI1-occupied genes contain linked EVI1 and activator protein (AP)1 DNA binding sites, and this find

202 -response element (HRE)-1, HRE-2, and distal activator protein (AP-1) sites.

203 opy map of APC/C in complex with the Cdh1 co-activator protein (APC/C(Cdh1)) bound to a D-box peptide

204 In the presence of the LPL activator protein apoC-II, more of apoC-I or apoC-III wa

205 Its activator proteins are members of the AAA+ superfamily a

206 C/C-Cdh1 through phosphorylation of the Cdh1 activator protein at multiple sites.

207 ned primarily by the genomic distribution of activator proteins at enhancers and promoters.

208 transcription in bacteria requires specific activator proteins, bacterial enhancer binding protein (

209 ced ITGA5 promoter activity through an AP-1 (activator protein)-binding site proximal to the transcri

210 like Wp, interacts with the B cell-specific activator protein BSAP/Pax5.

211 Pax5/B cell lineage specific activator protein (BSAP) is a B lineage-specific regulat

212 the first time that B-cell lineage specific activator protein (BSAP), also known as paired box 5 (PA

213 These GAF domain dimers regulate sigma(54) activator proteins by holding the ATPase domains in an i

214 tested the hypothesis that the Ca2+-binding activator protein calmodulin (CaM) is the primary decode

215 ed gene regulation and another way that this activator protein can repress protein expression.

216 The catabolite activator protein (CAP) of Escherichia coli is an exempl

217 cAMP to the Escherichia coli catabolite gene activator protein (CAP) produces a conformational change

218 of DNA to several variants of the catabolite activator protein (CAP) that differentially populate the

219 cyclic AMP (cAMP) binding to the catabolite activator protein (CAP), a transcriptional activator tha

220 x comprising the Escherichia coli catabolite activator protein (CAP), RNA polymerase holoenzyme (RNAP

221 t to a challenging test case: the catabolite activator protein (CAP).

222 TAP) [homolog of Escherichia coli catabolite activator protein (CAP)], T. thermophilus RNAP sigma(A)

223 ated allosteric transition in the catabolite activator protein (CAP; also known as the cAMP receptor

224 osidase and beta-hexosaminidases, and of GM2-activator protein, cause infantile (with tetraparesis, d

225 checkpoint proteins Mad2, Mad3 and APC/C co-activator protein Cdc20), we reveal the molecular basis

226 Substrates are recruited to the APC/C by activator proteins (Cdc20 or Cdh1), but it is not known

227 by this ubiquitin ligase depends on related activator proteins, Cdc20 and Cdh1, which bind and activ

228 CdhA, the A. nidulans homologue of the APC/C activator protein Cdh1, in gamma-tubulin-dependent inact

229 of CO rebinding to carbon monoxide oxidation activator protein (ChCooA) are measured over a wide temp

230 hibitor with enhanced affinity for circadian activator proteins Clock and Bmal1.

231 The Sum1 repressor and Ndt80 activator proteins control middle promoters by binding t

232 of the heme in the carbon monoxide oxidation activator protein (CooA) from the thermophilic anaerobic

233 We show how mRNA substrate and the activator proteins Dcp1 and Edc1 influence the dynamic e

234 e transcription factor BSAP (B-cell-specific activator protein) directly interacts with Dleu2, the ho

235 ted for p150(Glued), a subunit of the dynein activator protein dynactin.

236 inhibitor protein (IRP) binding and increase activator protein (eIF4F) binding identifies IRE-RNA as

237 though this process is known to involve a co-activator protein (either Cdc20 or Cdh1) together with c

238 by competing with the forkhead transcription activator protein Fkh2p for binding to Mcm1p through pro

239 RP2 has been considered to be a GTPase activator protein for ARL3 and to play a role in the tra

240 Saposin B (Sap B) is an essential activator protein for arylsulfatase A in the hydrolysis

241 Ca(2+)-dependent activator protein for secretion (CAPS) is an essential f

242 We studied the role of calcium-activator protein for secretion (CAPS) proteins in neuro

243 Calcium-dependent activator protein for secretion 1 (CAPS1) is a multidoma

244 ns with known roles (CAPS [calcium-dependent activator protein for secretion 1], Munc13-2, RIM1, and

245 CAPS (Ca(2+)-dependent activator protein for secretion) functions in priming Ca

246 sembly and is also found in Ca(2+)-dependent activator protein for secretion.

247 etween short peptide motifs in repressor and activator proteins for interaction with a common binding

248 activity and/or ability to interact with the activator proteins, GCAPs.

249 The GM2 activator protein (GM2AP) is an 18 kDa nonenzymatic acce

250 The GM2 activator protein (GM2AP) is an accessory protein requir

251 The GM2 activator protein (GM2AP) is an accessory protein that i

252 ower DNA packaging velocity, and required an activator protein, gp16 for rapid firing of ATPases.

253 -dependent nuclear transcription factor heme activator protein (Hap1p).

254 urs by interactions between a self-enhancing activator protein, HetR, and a diffusible pentapeptide i

255 scription factors, including four catabolite activator protein homologues.

256 complexes in a reaction in which specialized activator proteins hydrolyse ATP.

257 Ca(2+)-dependent activator protein in secretion 1 (CAPS-1; CADPS/UNC31) a

258 ression levels of the underlying ligand-free activator proteins in the device.

259 Overexpression of these activator proteins in vivo increases the abundance of GL

260 ASK1 phosphorylation of Daxx, an ASK1 activator protein, increases Daxx accumulation in cells

261 ed signaling via GLP-1 receptor or the CREBP activator protein kinase A thus offers a way to rescue i

262 The liver-enriched transcriptional activator protein (LAP) isoform of CCAAT/enhancer bindin

263 both enzyme complexes, suggesting that this activator protein may regulate a subclass of human deubi

264 apoptotic BCL-2 repertoire to promote direct activator protein-mediated MOMP.

265 the key control region and indicate that an activator protein modulates leukotoxin transcription.

266 e promoter, P(m), requires the phage-encoded activator protein Mor and the bacterial RNA polymerase.

267 -bound sites by the SAP domain-containing co-activator protein myocardin, and we show that paired sit

268 netically removing PTG, a glycogen synthesis activator protein, nearly completely eliminates Lafora b

269 The bacterial activator protein NorR binds to enhancer-like elements,

270 Bid is a proapopotic activator protein of the Bcl-2 family that plays a pivot

271 Activator protein one (AP1) (jun/fos) factors comprise a

272 or protein (CRP, also called catabolite gene activator protein or CAP) plays a key role in metabolic

273 e typically marked by the co-transcriptional activator protein p300 or by groups of cell-expressed tr

274 oligomers were formed in the presence of the activator protein p7/p15Bid.

275 Channel activity is maintained by PKC activators, protein phosphatase inhibitors, or pseudo-ph

276 ransactivator under the control of the liver activator protein promotor with transgenic mice carrying

277 The network of activator protein-protein interactions (PPIs) that under

278 The activator protein PspF was not involved in the PspA-TatA

279 vities (AAA+) domain of the Escherichia coli activator protein, PspF, using nucleotide-metal fluoride

280 mutations in PURA, encoding transcriptional activator protein Pur-alpha, within the critical region.

281 es cerevisiae (Sc), the generalist repressor-activator protein Rap1 now directs the Ifh1-Fhl1 module

282 l DNA binding transcription factor repressor activator protein Rap1p interacts directly with TBP.

283 usively by the replication and transcription activator protein RTA (open reading frame 50 [ORF50] gen

284 cs, which are composed of human sphingolipid activator protein saposin A and a small number of phosph

285 at acidic pH values by cationic sphingolipid activator proteins (SAPs), presenting lipids to their re

286 ely accepted model, the steroid receptor RNA activator protein (SRA protein; SRAP) modulates the tran

287 ning 1 (ZNHIT1) to block Snf2-related CREBBP activator protein (SRCAP) activity and prevents the depo

288 ce and chemistry of the motifs that bind the activator protein SRSF1, but it is not improved by incre

289 en complexes requires the ATPase activity of activator proteins that bind remotely upstream of the tr

290 f the ATPase site in an AAA+ transcriptional activator protein, the phage shock protein F (PspF), by

291 though there is considerable focus on kinase activator proteins, the importance of specific T-loop ph

292 its require the action of a 'transcriptional activator' protein to open the promoter and initiate tra

293 omote the proteasomal degradation of the ATR activator protein topoisomerase-IIbeta-binding protein 1

294 ression is controlled by the transcriptional activator protein ToxT.

295 ive conformation and disrupts binding to its activator protein TPX2, which impairs Aurora A localizat

296 respiratory growth and regulated by the heme activator protein transcriptional activation complex.

297 omplement of a gene encoding a transcription activator protein (TrAP).

298 comprises Thermus thermophilus transcription activator protein TTHB099 (TAP) [homolog of Escherichia

299 The activator proteins undergo regulated assembly from inact

300 controls growth through a transcriptional co-activator protein, Yorkie.